| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cullinan Therapeutics, Inc. (CGEM) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 23 sells. CGEM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.96M | $146.37M | - | |
| CEO | 420.7K | $6.87M | - | |
| Other | 169.5K | $2.77M | - | |
| Other | 135.4K | $2.21M | - | |
| Other | 132.6K | $2.17M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2021 | Zawel Leigh82 | See Remarks | Sell | 19,574 | $25.00 | $489,350.00 | -34.4% | -46.6% | -49.5% | |
| Oct 7, 2021 | Zawel Leigh82 | See Remarks | Sell | 1,079 | $25.00 | $26,975.00 | -1.9% | -36.0% | -48.3% | |
| Sep 20, 2021 | Michaelson Jennifer65 | See Remarks | Sale+OE | 4,000 | $24.51 | $98,048.00 | -7.9% | -34.8% | -49.8% | |
| Sep 20, 2021 | Zawel Leigh82 | See Remarks | Sell | 7,468 | $25.16 | $187,894.88 | -11.4% | -34.8% | -49.8% | |
| Sep 16, 2021 | Gadicke Ansbert85 | Director, 10% Owner | Sell | 3,556 | $29.06 | $103,337.36 | - | -44.7% | -56.6% | |
| Sep 16, 2021 | Ubs Oncology Impact Fund L.P.89 | 10% Owner | Sell | 3,124 | $29.06 | $90,783.44 | - | -44.7% | -56.6% | |
| Sep 15, 2021 | Gadicke Ansbert85 | Director, 10% Owner | Sell | 15,401 | $29.17 | $449,174.04 | - | -46.2% | -55.0% | |
| Sep 15, 2021 | Ubs Oncology Impact Fund L.P.89 | 10% Owner | Sell | 13,531 | $29.17 | $394,635.02 | - | -46.2% | -55.0% | |
| Sep 13, 2021 | Ubs Oncology Impact Fund L.P.89 | 10% Owner | Sell | 23,253 | $29.23 | $679,738.19 | -0.1% | -44.2% | -54.8% | |
| Sep 13, 2021 | Gadicke Ansbert85 | Director, 10% Owner | Sell | 26,468 | $29.23 | $773,719.99 | -0.1% | -44.2% | -54.8% |